EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored

Mengjie Zhu, Yijie Song iD, Yu Xu iD, Hongxi Xu

International Journal of Molecular Sciences · 02.07.2023 · 24 (13) · 11004

DOI: 10.3390/ijms241311004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.07.2023. Verfasst von Mengjie Zhu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease, Microbiota. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 174 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the NSFC-Joint Foundation of Yunnan Province, the Guangdong Province Key Area R&D Program of China, Guangdong Province Key Area R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a complex multifactorial chronic inflammatory disease, that includes Crohn’s disease (CD) and ulcerative colitis (UC), having progressively increasing global incidence. Disturbed intestinal flora has been highlighted as an important feature of IBD and offers promising strategies for IBD remedies. A brief overview of the variations occurring in intestinal flora during IBD is presented, and the role of the gut microbiota in intestinal barrier maintenance, immune and metabolic regulation, and the absorption and supply of nutrients is reviewed. More importantly, we review drug research on gut microbiota in the past ten years, including research on clinical and natural drugs, as well as adjuvant therapies, such as Fecal Microbiota Transplantation and probiotic supplements. We also summarize the interventions and mechanisms of these drugs on gut microbiota.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesColitis, UlcerativeCrohn DiseaseMicrobiotaHumansIntestines

Stichwörter der Autor:innen

gut microbiomeimmunityinflammatory bowel diseasemetabolitesnatural productssynthetic drugs

Autor:innen und Institutionen

  • School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

ORCID-Profile: Yijie Song, Yu Xu

Förderung

  • the NSFC-Joint Foundation of Yunnan Province
  • the Guangdong Province Key Area R&D Program of China
  • Guangdong Province Key Area R&D Program of China
  • NSFC-Joint Foundation of Yunnan Province

Zitieren

APA

Zhu, M., Song, Y., Xu, Y., & Xu, H. (2023). Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored. International Journal of Molecular Sciences, 24(13), 11004. https://doi.org/10.3390/ijms241311004

Vancouver

Zhu M, Song Y, Xu Y, Xu H. Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored. International Journal of Molecular Sciences. 2023;24(13):11004. doi:10.3390/ijms241311004

BibTeX
@article{Zhu2023,
  author = {Zhu, Mengjie and Song, Yijie and Xu, Yu and Xu, Hongxi},
  title = {Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {13},
  pages = {11004},
  doi = {10.3390/ijms241311004}
}
Kostenlos starten →